Winald Gerritsen
Overview
Explore the profile of Winald Gerritsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
2851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petrylak D, Ratta R, Matsubara N, Korbenfeld E, Gafanov R, Mourey L, et al.
J Clin Oncol
. 2025 Mar;
:JCO2401283.
PMID: 40043230
Purpose: The standard of care for metastatic castration-resistant prostate cancer (mCRPC) after second-generation androgen receptor pathway inhibitor (ARPI) therapy is still docetaxel. The randomized, double-blind, phase III KEYNOTE-921 trial (Clinicaltrials.gov...
2.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell
. 2022 Sep;
40(9):999-1009.e6.
PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
3.
Bellmunt J, de Wit R, Fradet Y, Climent M, Petrylak D, Lee J, et al.
Clin Cancer Res
. 2022 Mar;
28(10):2050-2060.
PMID: 35247908
Purpose: In an exploratory analysis, we investigated the association between programmed death ligand 1 (PD-L1), tumor mutational burden (TMB), T-cell-inflamed gene expression profile (TcellinfGEP), and stromal signature with outcomes of...
4.
van Putten E, Kleijn A, van Beusechem V, Noske D, Lamers C, de Goede A, et al.
Clin Cancer Res
. 2022 Feb;
28(8):1572-1585.
PMID: 35176144
Purpose: Testing safety of Delta24-RGD (DNX-2401), an oncolytic adenovirus, locally delivered by convection enhanced delivery (CED) in tumor and surrounding brain of patients with recurrent glioblastoma. Patients And Methods: Dose-escalation...
5.
Vogelzang N, Beer T, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, et al.
JAMA Oncol
. 2022 Feb;
8(4):546-552.
PMID: 35142815
Importance: DCVAC/PCa is an active cellular immunotherapy designed to initiate an immune response against prostate cancer. Objective: To evaluate the efficacy and safety of DCVAC/PCa plus chemotherapy followed by DCVAC/PCa...
6.
Simnica D, Smits M, Willscher E, Fanchi L, Kloots I, van Oort I, et al.
JCO Precis Oncol
. 2022 Jan;
4:1374-1385.
PMID: 35050788
Purpose: Although most patients with microsatellite instable (MSI) metastatic castration-resistant prostate cancer (mCRPC) respond to immune checkpoint blockade (ICB), only a small subset of patients with microsatellite stable (MSS) tumors...
7.
Benoist G, van Oort I, Boerrigter E, Verhaegh G, van Hooij O, Groen L, et al.
Clin Chem
. 2020 May;
66(6):842-851.
PMID: 32408351
Background: Several treatment options were recently added for metastatic castration-resistant prostate cancer (mCRPC). However, response to therapy is variable, and biomarkers that can guide treatment selection and response evaluation are...
8.
Woolmore A, Arnold D, Blay J, Buske C, Carrato A, Gerritsen W, et al.
Oncologist
. 2020 Apr;
25(10):e1428-e1432.
PMID: 32333623
No abstract available.
9.
Melief C, Welters M, Vergote I, Kroep J, Kenter G, Ottevanger P, et al.
Sci Transl Med
. 2020 Mar;
12(535).
PMID: 32188726
Therapeutic cancer vaccines have effectively induced durable regressions of premalignant oncogenic human papilloma virus type 16 (HPV16)-induced anogenital lesions. However, the treatment of HPV16-induced cancers requires appropriate countermeasures to overcome...
10.
van Wilpe S, Koornstra R, Den Brok M, De Groot J, Blank C, de Vries J, et al.
Oncoimmunology
. 2020 Mar;
9(1):1731942.
PMID: 32158624
Lactate dehydrogenase (LDH) levels are inversely related with response to checkpoint inhibitors. Elevated LDH levels are the product of enhanced glycolytic activity of the tumor and tumor necrosis due to...